or pharmaceutically acceptable salts thereof and (b) one or more at least one compound targeting, decreasing or inhibiting the intrinsic ATPase activity of Hsp90 and/or degrading, targeting, decreasing or inhibiting the Hsp90 client proteins via the ubiquitin proteosome pathway the uses of such combination in the treatment or prevention of proliferative diseases and methods of treating a subject suffering.
